Literature DB >> 7901227

Differential expression of P-glycoprotein genes in primary rat hepatocyte culture.

C H Lee1, G Bradley, J T Zhang, V Ling.   

Abstract

The multidrug resistance (MDR)-associated protein, P-glycoprotein (Pgp), is expressed on the bile canalicular surface of hepatocytes, where it is thought to function in the detoxification of xenobiotics or in the transport of specific metabolites. Several studies have shown that Pgp expression in rat liver can be perturbed in vivo and in vitro; however, it is not known which of the 3 Pgp genes (class I, II, or III) are involved. In rodents, the class I and II Pgp genes have been shown to mediate MDR while the class III gene apparently does not. In this report, we have used gene-specific probes generated from the 3'-untranslated regions of the three rat Pgp genes (Deuchars et al.: Biochim. Biophys. Acta, 1130:157-165, 1992) to investigate Pgp gene expression in primary rat hepatocytes. We observed that the class II Pgp mRNA, the least abundant in the intact liver, is dramatically increased in culture over a 48 h period, while the class I Pgp showed only a modest increase in mRNA level. In contrast, the class III Pgp mRNA, which is the most abundant in the intact liver, exhibited a gradual decline. In rat liver hepatocytes, different culture conditions, as well as drugs such as cytochalasin D and colchicine, appear to affect the level of the class II Pgp gene expression. Moreover, under all these conditions, there is a strong correlation between the level of the class II Pgp and cytoskeletal (actin and tubulin) mRNAs. Thus, there may be a common mechanism regulating the expression of cytoskeletal protein genes and the class II Pgp gene. These findings have implications for our understanding of the regulation of Pgp gene expression in normal and malignant tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901227     DOI: 10.1002/jcp.1041570223

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  14 in total

1.  Evaluation of (99)  (m)TcN-MPO as a new myocardial perfusion imaging agent in normal dogs and in an acute myocardial infarction canine model: comparison with (99)  (m)Tc-sestamibi.

Authors:  Lihong Bu; Renfei Li; Zhongnan Jin; Xiaofei Wen; Shuang Liu; Baofeng Yang; Baozhong Shen; Xiaoyuan Chen
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

2.  Differential expression of ABC transporters (MDR1, MRP1, BCRP) in developing human embryos.

Authors:  A Konieczna; B Erdösová; R Lichnovská; M Jandl; K Cížková; J Ehrmann
Journal:  J Mol Histol       Date:  2011-10-20       Impact factor: 2.611

3.  Minimizing liver uptake of cationic Tc radiotracers with ether and crown ether functional groups.

Authors:  Young-Seung Kim; Fan Wang; Shuang Liu
Journal:  World J Hepatol       Date:  2010-01-27

4.  Induction of P-glycoprotein mRNA transcripts by cycloheximide in animal tissues: evidence that class I Pgp is transcriptionally regulated whereas class II Pgp is post-transcriptionally regulated.

Authors:  C H Lee
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

5.  Physiological oxygen tensions modulate expression of the mdr1b multidrug-resistance gene in primary rat hepatocyte cultures.

Authors:  K I Hirsch-Ernst; T Kietzmann; C Ziemann; K Jungermann; G F Kahl
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

6.  Tc-99m-N-MPO: novel cationic Tc-99m radiotracer for myocardial perfusion imaging.

Authors:  Young-Seung Kim; Jianjun Wang; Alexis Broisat; David K Glover; Shuang Liu
Journal:  J Nucl Cardiol       Date:  2008-04-21       Impact factor: 5.952

7.  Mechanism for myocardial localization and rapid liver clearance of Tc-99m-N-MPO: a new perfusion radiotracer for heart imaging.

Authors:  Young-Seung Kim; Jiyun Shi; Shizhen Zhai; Guihua Hou; Shuang Liu
Journal:  J Nucl Cardiol       Date:  2009-03-14       Impact factor: 5.952

8.  Evaluation of (64)Cu(DO3A-xy-TPEP) as a potential PET radiotracer for monitoring tumor multidrug resistance.

Authors:  Shuang Liu; Young-Seung Kim; Shizhen Zhai; Jiyun Shi; Guihua Hou
Journal:  Bioconjug Chem       Date:  2009-04       Impact factor: 4.774

Review 9.  P-glycoprotein, multidrug resistance and tumor progression.

Authors:  G Bradley; V Ling
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

Review 10.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.